As FABP2 is a validated marker of enterocyte microdamage and higher intestinal permeability [30], an underlying “leaky gut” syndrome may be a proposed explanatory factor of the probiotic’s influence on liver function. This evidence concerns the gene FABP2 and Down syndrome.